<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2020 (12) TMI 66 - MADRAS HIGH COURT</title>
    <link>https://www.taxtmi.com/caselaws?id=401267</link>
    <description>Imported Inositol NF 12 declared as not intended for medicinal use was treated as falling within the exemption scheme for substances outside medicinal manufacture. Because the disclosed end use was non-pharma, including food, nutraceutical and beverage applications, the insistence on a Form 10 or Form 10-A licence was held inapplicable. The authorities&#039; licensing objection was further weakened by the absence of any dispute on the declared purpose of import. Release of the goods was permitted on the importer&#039;s undertaking to restrict sales to non-pharma users and to provide end-user details and transactional reconciliation, which was considered sufficient to protect regulatory compliance.</description>
    <language>en-us</language>
    <pubDate>Tue, 24 Nov 2020 00:00:00 +0530</pubDate>
    <lastBuildDate>Fri, 07 Jan 2022 12:06:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=629198" rel="self" type="application/rss+xml"/>
    <item>
      <title>2020 (12) TMI 66 - MADRAS HIGH COURT</title>
      <link>https://www.taxtmi.com/caselaws?id=401267</link>
      <description>Imported Inositol NF 12 declared as not intended for medicinal use was treated as falling within the exemption scheme for substances outside medicinal manufacture. Because the disclosed end use was non-pharma, including food, nutraceutical and beverage applications, the insistence on a Form 10 or Form 10-A licence was held inapplicable. The authorities&#039; licensing objection was further weakened by the absence of any dispute on the declared purpose of import. Release of the goods was permitted on the importer&#039;s undertaking to restrict sales to non-pharma users and to provide end-user details and transactional reconciliation, which was considered sufficient to protect regulatory compliance.</description>
      <category>Case-Laws</category>
      <law>Customs</law>
      <pubDate>Tue, 24 Nov 2020 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=401267</guid>
    </item>
  </channel>
</rss>